Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 348

1.

PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.

Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Domínguez-Franjo P, Piris MA.

Am J Surg Pathol. 2008 Aug;32(8):1252-7. doi: 10.1097/PAS.0b013e318165b0d6.

PMID:
18594468
2.

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.

Boudová L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S, Diehl V, Müller-Hermelink HK, Rüdiger T.

Blood. 2003 Nov 15;102(10):3753-8. Epub 2003 Jul 24.

3.

Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis.

Churchill HR, Roncador G, Warnke RA, Natkunam Y.

Hum Pathol. 2010 Dec;41(12):1726-34. doi: 10.1016/j.humpath.2010.05.010. Epub 2010 Sep 9.

PMID:
20825974
4.

Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.

Sohani AR, Jaffe ES, Harris NL, Ferry JA, Pittaluga S, Hasserjian RP.

Am J Surg Pathol. 2011 Nov;35(11):1666-78. doi: 10.1097/PAS.0b013e31822832de.

PMID:
21997687
5.

Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.

Muenst S, Hoeller S, Dirnhofer S, Tzankov A.

Hum Pathol. 2009 Dec;40(12):1715-22. doi: 10.1016/j.humpath.2009.03.025. Epub 2009 Aug 19.

PMID:
19695683
6.

Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.

Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, Piris MA.

Mod Pathol. 2009 Aug;22(8):1006-15. doi: 10.1038/modpathol.2009.54. Epub 2009 May 22.

7.

Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.

Treetipsatit J, Metcalf RA, Warnke RA, Natkunam Y.

Hum Pathol. 2015 Jan;46(1):74-83. doi: 10.1016/j.humpath.2014.09.009. Epub 2014 Oct 8.

PMID:
25456392
8.

Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.

Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA.

Am J Surg Pathol. 2003 Oct;27(10):1346-56.

PMID:
14508396
9.
11.
12.

Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site.

Cotta CV, Coleman JF, Li S, Hsi ED.

Histopathology. 2011 Dec;59(6):1194-203. doi: 10.1111/j.1365-2559.2011.04054.x.

PMID:
22175899
13.

Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers.

Rodriguez-Justo M, Attygalle AD, Munson P, Roncador G, Marafioti T, Piris MA.

Mod Pathol. 2009 Jun;22(6):753-61. doi: 10.1038/modpathol.2009.12. Epub 2009 Mar 27.

14.

Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.

Scheidt V, Hansmann ML, Schuhmacher B, Döring C, Hartmann S.

Hum Pathol. 2017 Feb;60:129-136. doi: 10.1016/j.humpath.2016.10.008. Epub 2016 Nov 2.

PMID:
27816718
15.

T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.

Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH.

Hum Pathol. 2005 Jan;36(1):10-5.

PMID:
15712176
16.

The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.

Lin P, Medeiros LJ, Wilder RB, Abruzzo LV, Manning JT, Jones D.

Histopathology. 2004 Jun;44(6):561-9.

PMID:
15186271
17.

Nodular lymphocyte predominant Hodgkin lymphoma. An immunophenotypic reappraisal based on a single-institution experience.

Uherova P, Valdez R, Ross CW, Schnitzer B, Finn WG.

Am J Clin Pathol. 2003 Feb;119(2):192-8.

PMID:
12579988
18.

[Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].

Liu YH, Zhuang HG, Lin HL, Wu QL, Luo DL, Li L, Luo XL.

Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):594-8. Chinese.

PMID:
17243292
19.

T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.

Van Loo P, Tousseyn T, Vanhentenrijk V, Dierickx D, Malecka A, Vanden Bempt I, Verhoef G, Delabie J, Marynen P, Matthys P, De Wolf-Peeters C.

Haematologica. 2010 Mar;95(3):440-8. doi: 10.3324/haematol.2009.009647. Epub 2009 Oct 1.

20.

Follicular hodgkin lymphoma: a histopathologic study.

Kansal R, Singleton TP, Ross CW, Finn WG, Padmore RF, Schnitzer B.

Am J Clin Pathol. 2002 Jan;117(1):29-35.

PMID:
11789727

Supplemental Content

Support Center